CARCINOMA, PANCREATIC DUCTAL

Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear

Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New hope for deadly cancer: First-in-Human trial tests engineered immune cells

Disease control Not yet recruiting

This trial is testing a new type of personalized immune cell therapy (CAR-T) for advanced pancreatic cancer that has stopped responding to standard treatments. Doctors will collect a patient's own immune cells, genetically modify them to target a protein called CD318 found on pan…

Matched conditions: CARCINOMA, PANCREATIC DUCTAL

Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

CARCINOMA, PANCREATIC DUCTAL

Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear

New hope for deadly cancer: First-in-Human trial tests engineered immune cells